Eris Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Dec' 23	Sep' 23	Jun' 23	Mar' 23	Dec' 22

Sales

324.41

409.71

411.29

314.58

332.01

Operating profit

74.43

144.49

155.50

111.49

126.39

Interest

15.14

6.55

6.84

2.96

3.14

Gross profit

62.73

144.92

152.69

112.79

126.73

EPS (Rs)

2.33

8.66

8.14

6.46

7.31

Other income

3.43

6.98

4.03

4.26

3.48

Stock adjustment

4.65

-2.95

-25.25

-6.06

11.93

Raw material

23.75

28.64

26.17

25.07

25.55

Power and fuel

-

-

-

-

-

Employee expenses

80.69

81.10

90.36

60.63

61.75

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

140.90

158.44

164.50

123.45

106.39

Provisions made

-

-

-

-

-

Depreciation

28.08

25.00

20.16

17.28

16.50

Taxation

2.99

2.11

21.78

7.67

10.85

Net profit / loss

31.66

117.81

110.74

87.84

99.38

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

13.60

13.60

13.60

13.60

13.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

22.94

35.27

37.81

35.44

38.07

GPM (%)

19.13

34.78

36.76

35.38

37.77

NPM (%)

9.66

28.27

26.66

27.55

29.62